HHS, DOD invest to expand U.S. COVID-19 test production
The departments of Health and Human Services and Defense this weekend announced a pair of contracts to expand domestic COVID-19 testing capacity. HHS and DOD awarded to Hologic, Inc. $119 million to expand the supplier’s production capacity for COVID-19 tests made at facilities in Wisconsin, Maine and California.
The funds are expected to increase Hologic’s production capacity to 13 million tests per month by January 2022.
The agencies also announced a $12.7 million contract with InBios International, Inc., to expand production of two rapid point-of-care SARS-CoV-2 tests. The funds will enable InBios to reach a production capacity of 400,000 units per week by May 2021.
Related News Articles
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…